Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0FW2A
|
|||
Former ID |
DNCL003687
|
|||
Drug Name |
LEO 80185
|
|||
Synonyms |
Taclonex
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Psoriasis vulgaris [ICD-11: EA90; ICD-9: 696] | Phase 4 | [1] | |
Plaque psoriasis [ICD-11: EA90.0; ICD-10: L40.0] | Phase 2 | [2] | ||
Company |
LEO Pharma
|
|||
Structure |
Download2D MOL |
|||
Formula |
C55H77FO10
|
|||
Canonical SMILES |
CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC.CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C
|
|||
InChI |
1S/C28H37FO7.C27H40O3/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5;1-17(6-13-25(29)20-8-9-20)23-11-12-24-19(5-4-14-27(23,24)3)7-10-21-15-22(28)16-26(30)18(21)2/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3;6-7,10,13,17,20,22-26,28-30H,2,4-5,8-9,11-12,14-16H2,1,3H3/b;13-6+,19-7+,21-10-/t16-,19-,20-,21-,25-,26-,27-,28-;17-,22-,23-,24+,25-,26+,27-/m01/s1
|
|||
InChIKey |
CNXNMLQATFFYLX-ICTDYHGOSA-N
|
|||
CAS Number |
CAS 485805-18-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00924950) Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.